1.
Hepatitis B virus-induced hepatocellular carcinoma
by Xu, Cheng
Cancer letters, 2013, Vol.345 (2), p.216-222
2.
Expression of CD163 in the liver of patients with viral hepatitis
by Hiraoka, Atsushi
Pathology, research and practice, 2005, Vol.201 (5), p.379-384
3.
Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma
by Deng, Mengmeng
Cancer letters, 2016, Vol.383 (1), p.62-72
4.
Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein
by Zhang, Shuqin
Cancer letters, 2017, Vol.392, p.94-104
5.
Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis
by Chen, Shuzhen
Cancer letters, 2017, Vol.394, p.22-32
6.
The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway
by Chen, Yiwen
Cancer letters, 2016, Vol.380 (1), p.98-105
7.
Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis
by Gerber, Doron
Nature biotechnology, 2008, Vol.26 (9), p.1019-1027
8.
The Hepatitis B Virus Receptor
by Li, Wenhui
Annual review of cell and developmental biology, 2015, Vol.31 (1), p.125-147
9.
Fibrosis is not just fibrosis – basement membrane modelling and collagen metabolism differs between hepatitis B‐ and C‐induced injury
by Nielsen, M. J.
Alimentary pharmacology & therapeutics, 2016, Vol.44 (11-12), p.1242-1252
11.
Modeling chronic hepatitis B or C virus infection during antiviral therapy using an analogy to enzyme kinetics: Long-term viral dynamics without rebound and oscillation
by Takayanagi, Toshiaki
Computers in biology and medicine, 2013, Vol.43 (12), p.2021-2027
12.
micro-Opioid receptor activation prevents acute hepatic inflammation and cell death
by Chakass, Dania
Gut, 2007, Vol.56 (7), p.974-81
13.
Hepatitis B Virus PreS1 Facilitates Hepatocellular Carcinoma Development by Promoting Appearance and Self-renewal of Liver Cancer Stem Cells
by Liu, Zhixin
Cancer letters, 2017, Vol.400, p.149-160
14.
Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study
by Kouroumalis, E
Gut, 1998, Vol.42 (3), p.442-447
15.
Biogenesis, evolution and functional targets of microRNA-125a
by Potenza, Nicoletta
Molecular genetics and genomics : MGG, 2013, Vol.288 (9), p.381-389
16.
PHLDA3 overexpression in hepatocytes by endoplasmic reticulum stress via IRE1–Xbp1s pathway expedites liver injury
by Han, Chang Yeob Chang Yeob
Gut, 2015, Vol.65 (8), p.1377-1388
17.
XIAP discriminates between type I and type II FAS-induced apoptosis
by Strasser, Andreas
Nature (London), 2009, Vol.460 (7258), p.1035-1039
18.
Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells
by Pallett, Laura J
Nature medicine, 2015, Vol.21 (6), p.591-600
19.
Sodium-dependent taurocholic cotransporting polypeptide: a candidate receptor for human hepatitis B virus
by Seeger, Christoph
Gut, 2013, Vol.62 (8), p.1093-1095
20.
